Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baidi Boyuan
Suzhou, Jiangsu, Chinabodmed.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Suzhou BodMed (also known as Suzhou Baidi Boyuan Biotechnology) is a pioneering Chinese biotechnology company specializing in the development of mucosal RNA medicines. Founded in December 2021 and headquartered in Suzhou, China, the company leverages its proprietary MucoRD® mucosal delivery platform and ETP® tumor immune enhancement design platform to develop non-LNP, non-viral inhaled mRNA therapeutics. Its lead pipeline candidates include BMD003 (GenSci124), an inhaled CFTR mRNA freeze-dried formulation for cystic fibrosis, and BMD006, a first-in-class inhaled mRNA tumor-associated antigen dry powder vaccine for advanced lung cancer and solid tumors. BodMed aims to accelerate the clinical translation of RNA therapeutics to improve patient outcomes globally.
- Therapeutic areas
- PulmonologyOncology
- Modalities
- mRNA-based drugsBiologicVaccine
- Industry
- Biotech
02
Partnerships
GeneScience PharmaceuticalsPeking Union Medical College HospitalChinese Academy of Medical Sciences Cancer Hospital
Beyond the preview
Go deeper on Baidi Boyuan.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Baidi Boyuan.